Ashland Completes Acquisition o... (Materials Ashland Aqualon Functional Ing...)

Ashland Completes Acquisition of Hercules

Date:11/13/2008

Materials, Ashland Aqualon Functional Ingredients, Ashland Consumer Markets (Valvoline) and Ashland Distribution. To learn more about Ashland, visit http://www.ashland.com .

FORTUNE 500 is a registered trademark of Time Inc.

Forward-Looking Statements

This news release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The statements include those made with respect to Ashland's operating performance and Ashland's acquisition of Hercules Incorporated. These expectations are based upon a number of assumptions, including those mentioned within this news release. Performance estimates are also based upon internal forecasts and analyses of current and future market conditions and trends, management plans and strategies, weather, operating efficiencies and economic conditions, such as prices, supply and demand, cost of raw materials, and legal proceedings and claims (including environmental and asbestos matters). These risks and uncertainties may cause actual operating results to differ materially from those stated, projected or implied. Such risks and uncertainties with respect to Ashland's acquisition of Hercules include the possibility that the benefits anticipated from the Hercules transaction will not be fully realized; the substantial indebtedness Ashland has incurred to finance the acquisition may impair Ashland's financial condition; the restrictive covenants under the debt instruments may hinder the successful operation of Ashland's business; future cash flow may be insufficient to repay the debt; and other risks that are described in filings made by Ashland with the Securities and Exchange Commission (SEC). Although Ashland believes its expectations are based on reasonable assumptions, it cannot assure the expectations reflected herein will be achieved.

This forward-looking inform
'/>"/>

2

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Conseco Completes Transfer of Senior Health Insurance Company of Pennsylvania to Independent Trust
2. Hyperion Therapeutics Completes Phase 2 Data Analysis and Schedules End of Phase 2 Meeting With FDA for HPN-100 in the Chronic Treatment of Urea Cycle Disorders
3. Cardium Completes $6.0 Million Financing
4. PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF
5. TomoTherapy Completes Acquisition of Linear Accelerator Manufacturer in China
6. Phyhealth Completes $250,000 Funding
7. Response Biomedical Completes Initial Closing of an expected $5.0 Million Financing
8. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study
9. The RightThing Continues Drive: Completes Strong Q3
10. PreMD Inc. Completes Secured Debenture Financing
11. VA Suicide Prevention Panel Completes Draft Report

Post Your Comments:

Ashland Completes Acquisition o...(Materials Ashland Aqualon Functional Ing...),Health